Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Diabetes Mellitus HELP
Based on 99,695 articles since 2008
|||| 29 

These are the 99695 published articles about Diabetes Mellitus that originated from Worldwide during 2008-2017.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline USPSTF update: Screening for abnormal blood glucose, diabetes. 2016

Campos-Outcalt, Doug. ·Medical Director, Mercy Care Plan, Phoenix, AZ, USA. Email: campos-outcaltd@mercycareplan.com. ·J Fam Pract · Pubmed #27565101.

ABSTRACT: Screen all adults, ages 40 to 70 years, who are overweight or obese. Consider screening younger patients who have specific personal or family risk factors.

2 Guideline Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults. 2016

Aschner, Pablo M / Muñoz, Oscar Mauricio / Girón, Diana / García, Olga Milena / Fernández-Ávila, Daniel Gerardo / Casas, Luz Ángela / Bohórquez, Luisa Fernanda / Arango T, Clara María / Carvajal, Liliana / Ramírez, Doris Amanda / Sarmiento, Juan Guillermo / Colon, Cristian Alejandro / Correa G, Néstor Fabián / Alarcón R, Pilar / Bustamante S, Álvaro Andrés. ·Hospital Universitario San Ignacio, Bogota, Colombia; Pontificia Universidad Javeriana, Bogota, Colombia; Asociación Colombiana de Diabetes, Bogota, Colombia. · Hospital Universitario San Ignacio, Bogota, Colombia; Pontificia Universidad Javeriana, Bogota, Colombia. · Departamento de Epidemiología y Bioestadística. Pontificia Universidad Javeriana, Bogota, Colombia. · Asociación Colombiana de Endocrinología, Universidad del Valle, Cali, Colombia. · Federación diabetológica Colombiana, Bogota, Colombia; Universidad Nacional de Colombia, Bogota, Colombia. · Universidad de Antioquia, Medellin, Colombia. · Asociación Colombiana de Diabetes, Bogota, Colombia. · Universidad Nacional de Colombia, Bogota, Colombia. ·Colomb Med (Cali) · Pubmed #27546934.

ABSTRACT: In Colombia, diabetes mellitus is a public health program for those responsible for creating and implementing strategies for prevention, diagnosis, treatment, and follow-up that are applicable at all care levels, with the objective of establishing early and sustained control of diabetes. A clinical practice guide has been developed following the broad outline of the methodological guide from the Ministry of Health and Social Welfare, with the aim of systematically gathering scientific evidence and formulating recommendations using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology. The current document presents in summary form the results of this process, including the recommendations and the considerations taken into account in formulating them. In general terms, what is proposed here is a screening process using the Finnish Diabetes Risk Score questionnaire adapted to the Colombian population, which enables early diagnosis of the illness, and an algorithm for determining initial treatment that can be generalized to most patients with diabetes mellitus type 2 and that is simple to apply in a primary care context. In addition, several recommendations have been made to scale up pharmacological treatment in those patients that do not achieve the objectives or fail to maintain them during initial treatment. These recommendations also take into account the evolution of weight and the individualization of glycemic control goals for special populations. Finally, recommendations have been made for opportune detection of micro- and macrovascular complications of diabetes.

3 Guideline [CROATIAN GUIDELINES FOR THE PHARMACOTHERAPY OF TYPE 2 DIABETES]. 2016

Rahelić, Dario / Altabas, Velimir / Bakula, Miro / Balić, Stjepan / Balint, Ines / Marković, Biserka Bergman / Bicanić, Nenad / Bjelinski, Igor / Bozikov, Velimir / Varzić, Silvija Canecki / Car, Nikica / Berković, Maja Cigrovski / Orlić, Zeljka Crncevic / Deskin, Marin / Sunić, Ema Drvodelić / Tomić, Nives Gojo / Goldoni, Vesna / Gradiser, Marina / Mahecić, Davorka Herman / Balen, Marica Jandrić / Erzen, Dubravka Jurisić / Majanović, Sanja Klobucar / Kokić', Slaven / Krnic, Mladen / Kruljac, Ivan / Liberati-Cizmek, Ana-Marija / Martina, Luksić / Metelko, Zeljko / Mirosević, Gorana / Vrbica, Sanja Mlinaric / Renar, Ivana Pavlić / Petric, Dragomir / Prasek, Manja / Prpić-Kizevać, Ivana / Radman, Maja / Soldo, Dragan / Sarić, Tereza / Tesanović, Sandi / Kurir, Tina Ticinovic / Wensveen, Tamara Turk / Botica, Marija / Vrkljan, Milan / Rotkvic, Vanja Zjacić / Zorić, Cedomir / Krznarić, Zeljko. · ·Lijec Vjesn · Pubmed #27443001.

ABSTRACT: INTRODUCTION: The Croatian Association for Diabetes and Metabolic Disorders of the Croatian Medical Association has issued in 2011 the first national guidelines for the nutrition, education, self-control, and pharmacotherapy of diabetes type 2. According to the increased number of available medicines and new evidence related to the effectiveness and safety of medicines already involved in the therapy there was a need for update of the existing guidelines for the pharmacotherapy of type 2 diabetes in the Republic of Croatia. PARTICIPANTS: as co-authors of the Guidelines there are listed all members of the Croatian Association for Diabetes and Metabolic Diseases, as well as other representatives of professional societies within the Croatian Medical Association, who have contributed with comments and suggestions to the development of the Guidelines. EVIDENCE: These guidelines are evidence-based, according to the GRADE system (eng. Grading of Recommendations, Assessment, Development and Evaluation), which describes the level of evidence and strength of recommendations. CONCLUSIONS: An individual patient approach based on physiological principles in blood glucose control is essential for diabetes' patients management. Glycemic targets and selection of the pharmacological agents should be tailored to the patient, taking into account the age, duration of disease, life expectancy, risk of hypoglyce- mia, comorbidities, developed vascular and other complications as well as other factors. Because of all this, is of national interest to have a practical, rational and applicable guidelines for the pharmacotherapy of type 2 diabetes.

4 Guideline The Role of Interventional Radiology in the Treatment of Arterial Diabetic Foot Disease. 2016

Reekers, Jim A. ·Department of Radiology, G1.206, Academic Medical Center, University of Amsterdam, Meibergdreef 9, PO Box 22660, 1100 DD, Amsterdam, The Netherlands. j.a.reekers@amc.uva.nl. ·Cardiovasc Intervent Radiol · Pubmed #27435578.

ABSTRACT: -- No abstract --

5 Guideline Shoulder dystocia: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF). 2016

Sentilhes, Loïc / Sénat, Marie-Victoire / Boulogne, Anne-Isabelle / Deneux-Tharaux, Catherine / Fuchs, Florent / Legendre, Guillaume / Le Ray, Camille / Lopez, Emmanuel / Schmitz, Thomas / Lejeune-Saada, Véronique. ·Service de Gynécologie-Obstétrique, CHU Bordeaux, Bordeaux, France. Electronic address: loicsentilhes@hotmail.com. · Service de Gynécologie-Obstétrique, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France. · Collège National des Sages-Femmes, France; Service de Gynécologie-Obstétrique, Hôpital Necker, AP-HP, Paris, France. · Inserm U1153, EPidémiologie Obstétricale, Périnatale et Pédiatrique (Equipe EPOPé), CRESS, Paris, France. · Service de Gynécologie-Obstétrique, CHU Angers, Angers, France. · Maternité Port Royal, Hôpital Cochin, AP-HP, Paris, France. · Réanimation néonatale, Hôpital Clocheville, CHU Tours, Tours, France. · Service de Gynécologie Obstétrique, Hôpital Robert Debré, AP-HP, Paris, France. · Gynérisq, France; Service de Gynécologie-Obstétrique, Centre Hospitalier d'Auch, Auch, France. ·Eur J Obstet Gynecol Reprod Biol · Pubmed #27318182.

ABSTRACT: Shoulder dystocia (SD) is defined as a vaginal delivery in cephalic presentation that requires additional obstetric maneuvers to deliver the fetus after the head has delivered and gentle traction has failed. It complicates 0.5-1% of vaginal deliveries. Risks of brachial plexus birth injury (level of evidence [LE]3), clavicle and humeral fracture (LE3), perinatal asphyxia (LE2), hypoxic-ischemic encephalopathy (LE3) and perinatal mortality (LE2) increase with SD. Its main risk factors are previous SD and macrosomia, but both are poorly predictive; 50-70% of SD cases occur in their absence, and most deliveries when they are present do not result in SD. No study has proven that the correction of these risk factors (except gestational diabetes) would reduce the risk of SD. Physical activity is recommended before and during pregnancy to reduce the occurrence of some risk factors for SD (Grade C). In obese women, physical activity should be coupled with dietary measures to reduce fetal macrosomia and weight gain during pregnancy (Grade A). Women with gestational diabetes require diabetes care (diabetic diet, glucose monitoring, insulin if needed) (Grade A) because it reduces the risk of macrosomia and SD (LE1). Only two measures are proposed for avoiding SD and its complications. First, induction of labor is recommended in cases of impending macrosomia if the cervix is favorable at a gestational age of 39 weeks or more (professional consensus). Second, cesarean delivery is recommended before labor in three situations and during labor in one: (i) estimated fetal weight (EFW) >4500g if associated with maternal diabetes (Grade C), (ii) EFW >5000g in women without diabetes (Grade C), (iii) history of SD associated with severe neonatal or maternal complications (professional consensus), and finally during labor, (iv) in case of fetal macrosomia and failure to progress in the second stage, when the fetal head station is above +2 (Grade C). In cases of SD, it is recommended to avoid the following actions: excessive traction on the fetal head (Grade C), fundal pressure (Grade C), and inverse rotation of the fetal head (professional consensus). The McRoberts maneuver, with or without suprapubic pressure, is recommended first (Grade C). If it fails and the posterior shoulder is engaged, Wood's maneuver should be performed preferentially; if the posterior shoulder is not engaged, it is preferable to attempt to deliver the posterior arm next (professional consensus). It appears necessary to know at least two maneuvers to perform should the McRoberts maneuver fail (professional consensus). A pediatrician should be immediately informed of SD. The initial clinical examination should check for complications, such as brachial plexus injury or clavicle fracture (professional consensus). If no complications are observed, neonatal monitoring need not be modified (professional consensus). The implementation of practical training with simulation for all care providers in the delivery room is associated with a significant reduction in neonatal (LE3) but not maternal (LE3) injury. SD remains an unpredictable obstetric emergency. All physicians and midwives should know and perform obstetric maneuvers if needed, quickly but calmly.

6 Guideline Diabetes update: Your guide to the latest ADA standards. 2016

Johnson, Eric / Warren, Florence / Skolnik, Neil / Shubrook, Jay H. ·Altru Diabetes Center, Grand Forks, ND, USA. · Abington-Jefferson Health, Abington, PA, USA. · Temple University School of Medicine, Philadelphia, PA, USA. · Touro University, Vallejo, CA, USA. Email: jay.shubrook@tu.edu. ·J Fam Pract · Pubmed #27275934.

ABSTRACT: The authors highlight the latest changes in the ADA standards and review recommendations of particular relevance for family physicians.

7 Guideline Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular Edema. 2016

Puliafito, Carmen A / Cousins, Scott W / Bacharach, Jason / Gonzalez, Victor H / Holekamp, Nancy M / Merrill, Pauline T / Ohr, Matthew P / Parrish, Richard K / Riemann, Christopher D. · ·Ophthalmic Surg Lasers Imaging Retina · Pubmed #27096289.

ABSTRACT: The diabetic macular edema (DME) treatment paradigm has evolved as the understanding of the disease pathology has grown. Since 2012, four pharmacotherapies have been approved by the U.S. Food and Drug Administration for the treatment of DME. First-line treatment of DME with anti-vascular endothelial growth factor [VEGF] agents has become the gold standard; however, an appreciable percentage of patients do not respond to anti-VEGF therapies. In patients who inadequately respond to anti-VEGF therapies, the underlying disease pathology may be mediated by a multitude of growth factors and inflammatory cytokines. For these patients, corticosteroids are an attractive treatment option because they not only downregulate VEGF, but also an array of cytokines. The phase 3 MEAD and FAME trials demonstrated significant visual acuity improvements associated with dexamethasone and fluocinolone acetonide, respectively, in patients with DME; however, class-specific adverse events, including increased intraocular pressure and cataract development, must be considered before use. A panel of experts gathered during the 2015 annual meeting of the American Academy of Ophthalmology for a roundtable discussion focused on patient selection and adverse event management associated with the use of the 0.19 mg fluocinolone acetonide intravitreal implant.

8 Guideline Pharmacologic Management of Type 2 Diabetes: 2016 Interim Update. 2016

Anonymous761006. · ·Can J Diabetes · Pubmed #27032548.

ABSTRACT: -- No abstract --

9 Guideline Optometry Australia - Guidelines on the examination and management of patients with diabetes. 2016

Hanna, Simon / Anonymous30950. ·Optometry Australia, Diabetes Guidelines Working Group, Carlton, Victoria, Australia. oaanat@optometry.org.au. · ·Clin Exp Optom · Pubmed #26928922.

ABSTRACT: -- No abstract --

10 Guideline Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. 2016

Chamberlain, James J / Rhinehart, Andrew S / Shaefer, Charles F / Neuman, Annie. · ·Ann Intern Med · Pubmed #26928912.

ABSTRACT: DESCRIPTION: The American Diabetes Association (ADA) published the 2016 Standards of Medical Care in Diabetes (Standards) to provide clinicians, patients, researchers, payers, and other interested parties with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care. METHODS: The ADA Professional Practice Committee performed a systematic search on MEDLINE to revise or clarify recommendations based on new evidence. The committee assigns the recommendations a rating of A, B, or C, depending on the quality of evidence. The E rating for expert opinion is assigned to recommendations based on expert consensus or clinical experience. The Standards were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community was incorporated into the 2016 revision. RECOMMENDATIONS: The synopsis focuses on 8 key areas that are important to primary care providers. The recommendations highlight individualized care to manage the disease, prevent or delay complications, and improve outcomes.

11 Guideline Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Recommendation Statement. 2016

Anonymous2381050. · ·Am Fam Physician · Pubmed #26926415.

ABSTRACT: -- No abstract --

12 Guideline The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2015 edition. 2016

Taira, Naruto / Arai, Masami / Ikeda, Masahiko / Iwasaki, Motoki / Okamura, Hitoshi / Takamatsu, Kiyoshi / Nomura, Tsunehisa / Yamamoto, Seiichiro / Ito, Yoshinori / Mukai, Hirofumi. ·Department of Breast and Endocrine Surgery, Okayama University Hospital, Shikata-cho 2-5-1, Okayama, Okayama, 700-8558, Japan. ntaira@md.okayama-u.ac.jp. · Department of Clinical Genetic Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. · Department of Breast and Thyroid Surgery, Fukuyama City Hospital, Hiroshima, Japan. · Division of Epidemiology, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan. · Department of Psychosocial Rehabilitation, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. · Department of Obstetrics and Gynecology, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan. · Department of Breast and Thyroid Surgery, Kawasaki Medical School Hospital, Okayama, Japan. · Public Health Policy Research Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan. · Department of Breast Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. · Department of Oncology/Hematology, National Cancer Center Hospital East, Chiba, Japan. ·Breast Cancer · Pubmed #26873619.

ABSTRACT: -- No abstract --

13 Guideline AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT. 2016

Bailey, Timothy S / Grunberger, George / Bode, Bruce W / Handelsman, Yehuda / Hirsch, Irl B / Jovanovič, Lois / Roberts, Victor Lawrence / Rodbard, David / Tamborlane, William V / Walsh, John / Anonymous50858 / Anonymous60858. · ·Endocr Pract · Pubmed #26848630.

ABSTRACT: This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

14 Guideline IWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes. 2016

Bus, S A / Armstrong, D G / van Deursen, R W / Lewis, J E A / Caravaggi, C F / Cavanagh, P R / Anonymous590948. ·Department of Rehabilitation Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Southern Arizona Limb Salvage Alliance (SALSA), Department of Surgery, University of Arizona College of Medicine, Tucson, AZ, USA. · School of Healthcare Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK. · Cardiff and Vale University Health Board and Cardiff School of Health Science, Cardiff Metropolitan University, Cardiff, UK. · Vita-Salute San Raffaele University, Milan, Italy.; Diabetic Foot Clinic, Istituto Clinico Città Studi, Milan, Italy. · Department of Orthopaedics and Sports Medicine, University of Washington Medical Center, Seattle, WA, USA. · ·Diabetes Metab Res Rev · Pubmed #26813614.

ABSTRACT: -- No abstract --

15 Guideline The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. 2016

Hingorani, Anil / LaMuraglia, Glenn M / Henke, Peter / Meissner, Mark H / Loretz, Lorraine / Zinszer, Kathya M / Driver, Vickie R / Frykberg, Robert / Carman, Teresa L / Marston, William / Mills, Joseph L / Murad, Mohammad Hassan. ·NYU Lutheran Medical Center, Brooklyn, NY. Electronic address: ahingorani67@gmail.com. · Massachusetts General Hospital and Harvard Medical School, Boston, Mass. · University of Michigan, Ann Arbor, Mich. · University of Washington, Seattle, Wash. · UMass Memorial, Worcester, Mass. · Geisinger Health System, Danville, Pa. · Brown University, Alpert Medical School, Providence, RI. · Carl T. Hayden Veterans Affairs Medical Center, Phoenix, Ariz. · University Hospitals Case Medical Center, Cleveland, Ohio. · University of North Carolina School of Medicine, Chapel Hill, NC. · Baylor College of Medicine in Houston, Houston, Tex. · Mayo Clinic, Rochester, Minn. ·J Vasc Surg · Pubmed #26804367.

ABSTRACT: BACKGROUND: Diabetes mellitus continues to grow in global prevalence and to consume an increasing amount of health care resources. One of the key areas of morbidity associated with diabetes is the diabetic foot. To improve the care of patients with diabetic foot and to provide an evidence-based multidisciplinary management approach, the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine developed this clinical practice guideline. METHODS: The committee made specific practice recommendations using the Grades of Recommendation Assessment, Development, and Evaluation system. This was based on five systematic reviews of the literature. Specific areas of focus included (1) prevention of diabetic foot ulceration, (2) off-loading, (3) diagnosis of osteomyelitis, (4) wound care, and (5) peripheral arterial disease. RESULTS: Although we identified only limited high-quality evidence for many of the critical questions, we used the best available evidence and considered the patients' values and preferences and the clinical context to develop these guidelines. We include preventive recommendations such as those for adequate glycemic control, periodic foot inspection, and patient and family education. We recommend using custom therapeutic footwear in high-risk diabetic patients, including those with significant neuropathy, foot deformities, or previous amputation. In patients with plantar diabetic foot ulcer (DFU), we recommend off-loading with a total contact cast or irremovable fixed ankle walking boot. In patients with a new DFU, we recommend probe to bone test and plain films to be followed by magnetic resonance imaging if a soft tissue abscess or osteomyelitis is suspected. We provide recommendations on comprehensive wound care and various débridement methods. For DFUs that fail to improve (>50% wound area reduction) after a minimum of 4 weeks of standard wound therapy, we recommend adjunctive wound therapy options. In patients with DFU who have peripheral arterial disease, we recommend revascularization by either surgical bypass or endovascular therapy. CONCLUSIONS: Whereas these guidelines have addressed five key areas in the care of DFUs, they do not cover all the aspects of this complex condition. Going forward as future evidence accumulates, we plan to update our recommendations accordingly.

16 Guideline Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association. 2016

Munshi, Medha N / Florez, Hermes / Huang, Elbert S / Kalyani, Rita R / Mupanomunda, Maria / Pandya, Naushira / Swift, Carrie S / Taveira, Tracey H / Haas, Linda B. ·Beth Israel Deaconess Medical Center and Joslin Diabetes Center, Harvard Medical School, Boston, MA mmunshi@bidmc.harvard.edu. · Geriatric Research Education and Clinical Centers, Miami Veterans Affairs Healthcare System and University of Miami, Miami, FL. · Section of General Internal Medicine, The University of Chicago, Chicago, IL. · Johns Hopkins University School of Medicine, Baltimore, MD. · American Diabetes Association, Alexandria, VA. · Department of Geriatrics, Nova Southeastern University College of Osteopathic Medicine, Ft. Lauderdale, FL. · Kadlec Regional Medical Center, Richland, WA. · University of Rhode Island College of Pharmacy, Providence, RI. · Private Consultant, Seattle, WA. ·Diabetes Care · Pubmed #26798150.

ABSTRACT: Diabetes is more common in older adults, has a high prevalence in long-term care (LTC) facilities, and is associated with significant disease burden and higher cost. The heterogeneity of this population with regard to comorbidities and overall health status is critical to establishing personalized goals and treatments for diabetes. The risk of hypoglycemia is the most important factor in determining glycemic goals due to the catastrophic consequences in this population. Simplified treatment regimens are preferred, and the sole use of sliding scale insulin (SSI) should be avoided. This position statement provides a classification system for older adults in LTC settings, describes how diabetes goals and management should be tailored based on comorbidities, delineates key issues to consider when using glucose-lowering agents in this population, and provides recommendations on how to replace SSI in LTC facilities. As these patients transition from one setting to another, or from one provider to another, their risk for adverse events increases. Strategies are presented to reduce these risks and ensure safe transitions. This article addresses diabetes management at end of life and in those receiving palliative and hospice care. The integration of diabetes management into LTC facilities is important and requires an interprofessional team approach. To facilitate this approach, acceptance by administrative personnel is needed, as are protocols and possibly system changes. It is important for clinicians to understand the characteristics, challenges, and barriers related to the older population living in LTC facilities as well as the proper functioning of the facilities themselves. Once these challenges are identified, individualized approaches can be designed to improve diabetes management while lowering the risk of hypoglycemia and ultimately improving quality of life.

17 Guideline Recommendations for the appropriate management of diabetic macular edema: Light on DME survey and consensus document by an expert panel. 2016

Bandello, Francesco / Midena, Edoardo / Menchini, Ugo / Lanzetta, Paolo. ·Department of Ophthalmology, University Vita-Salute, San Raffaele Scientific Institute, Milan - Italy. · Department of Neuroscience-Ophthalmology, University of Padova, Padova - Italy. · University of Florence, Clinica Oculistica AOU Careggi, Florence - Italy. · Department of Medical and Biological Sciences-Ophthalmology, University of Udine, Udine - Italy.; Istituto Europeo di Microchirurgia Oculare, Udine - Italy. ·Eur J Ophthalmol · Pubmed #26776698.

ABSTRACT: PURPOSE: The Light on DME survey was designed to address several issues concerning the management of diabetic macular edema (DME) with the objective of producing practical recommendations for the appropriate treatment of this condition. METHODS: The recommendations considered aspects of DME treatment that are controversial and insufficiently supported by the evidence and were based on a consensus reached by an expert panel. Consensus was achieved by means of the Delphi method. Thirty-one Italian retinologists were asked to rate the appropriateness of a comprehensive set of scenarios typically encountered in the management of DME in clinical practice. The results of the appropriateness evaluation were analyzed by the study panel and a second assessment round was conducted for those scenarios on which no consensus was reached. RESULTS: Consensus was reached on several relevant aspects of current DME management, namely the initiation and course of treatment with anti-vascular endothelial growth factor (VEGF) therapy, assessment of the outcomes of anti-VEGF therapy based on both functional and morphologic outcomes, combination of anti-VEGF with laser therapy, and management of nonresponders to anti-VEGFs. A few issues, including the definition of DME based on novel diagnostic tools, the need for stable metabolic parameters before initiating anti-VEGF therapy, and the use of a second anti-VEFG after failure of the first anti-VEGF, proved controversial. CONCLUSIONS: A clear consensus among DME experts was reached on several relevant aspects of DME management. Based on this consensus, detailed and practical recommendations to guide ophthalmologists in the use of novel approaches to DME could be developed.

18 Guideline CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY. 2016

Garber, Alan J / Abrahamson, Martin J / Barzilay, Joshua I / Blonde, Lawrence / Bloomgarden, Zachary T / Bush, Michael A / Dagogo-Jack, Samuel / DeFronzo, Ralph A / Einhorn, Daniel / Fonseca, Vivian A / Garber, Jeffrey R / Garvey, W Timothy / Grunberger, George / Handelsman, Yehuda / Henry, Robert R / Hirsch, Irl B / Jellinger, Paul S / McGill, Janet B / Mechanick, Jeffrey I / Rosenblit, Paul D / Umpierrez, Guillermo E / Anonymous3250854 / Anonymous3260854. · ·Endocr Pract · Pubmed #26731084.

ABSTRACT: -- No abstract --

19 Guideline Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly. 2016

Baroni, M G / Giorgino, F / Pezzino, V / Scaroni, C / Avogaro, A. ·Endocrinology and Diabetes, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy. · Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro, Bari, Italy. · Endocrinology, Department of Clinical and Molecular Bio-Medicine, Cannizzaro Hospital, University of Catania, Catania, Italy. · Section of Endocrinology, Department of Medicine, University of Padova, Padua, Italy. · Section of Metabolic Diseases, Department of Medicine, University of Padova, Via Giustiniani, 2, 3128, Padua, Italy. angelo.avogaro@unipd.it. ·J Endocrinol Invest · Pubmed #26718207.

ABSTRACT: Hyperglycemia is a common feature associated with states of increased growth hormone secretion and glucocorticoid levels. The purpose of these guidelines is to assist clinicians and other health care providers to take evidence-based therapeutic decisions for the treatment of hyperglycemia in patients with growth hormone and corticosteroid excess. Both the SID and SIE appointed members to represent each society and to collaborate in Guidelines writing. Members were chosen for their specific knowledge in the field. Each member agreed to produce-and regularly update-conflicts of interest. The authors of these guidelines prepared their contributions following the recommendations for the development of Guidelines, using the standard classes of recommendation shown below. All members of the writing committee provided editing and systematic review of each part of the manuscript, and discussed the grading of evidence. Consensus was guided by a systematic review of all available trials and by interactive discussions.

20 Guideline WHS guidelines update: Diabetic foot ulcer treatment guidelines. 2016

Lavery, Lawrence A / Davis, Kathryn E / Berriman, Sandra J / Braun, Liza / Nichols, Adam / Kim, Paul J / Margolis, David / Peters, Edgar J / Attinger, Chris. ·Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas. · Cardinal Health Wound Management, Pompano Beach, Florida. · Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia. · Department of Orthopaedics, Sanford Health, Sioux Falls, South Dakota. · Department of Plastic Surgery, Georgetown University, School of Medicine, Washington, DC. · Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands. ·Wound Repair Regen · Pubmed #26663430.

ABSTRACT: -- No abstract --

21 Guideline IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. 2016

Lipsky, Benjamin A / Aragón-Sánchez, Javier / Diggle, Mathew / Embil, John / Kono, Shigeo / Lavery, Lawrence / Senneville, Éric / Urbančič-Rovan, Vilma / Van Asten, Suzanne / Anonymous1500943 / Peters, Edgar J G. ·Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.; University of Oxford, Oxford, UK. · La Paloma Hospital, Las Palmas de Gran Canaria, Spain. · Nottingham University Hospitals Trust, Nottingham, UK. · University of Manitoba, Winnipeg, MB, Canada. · WHO-collaborating Centre for Diabetes, National Hospital Organization, Kyoto Medical Center, Kyoto, Japan. · University of Texas Southwestern Medical Center and Parkland Hospital, Dallas, TX, USA. · Gustave Dron Hospital, Tourcoing, France. · University Medical Centre, Ljubljana, Slovenia. · University of Texas Southwestern Medical Center and Parkland Hospital, Dallas, TX, USA.; VU University Medical Centre, Amsterdam, The Netherlands. · ·Diabetes Metab Res Rev · Pubmed #26386266.

ABSTRACT: -- No abstract --

22 Guideline IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes. 2016

Game, F L / Attinger, C / Hartemann, A / Hinchliffe, R J / Löndahl, M / Price, P E / Jeffcoate, W J / Anonymous820943. ·Department of Diabetes and Endocrinology, Derby Teaching Hospitals NHS FT, Derby, UK. · Department of Plastic Surgery, Medstar Georgetown University. Hospital, Washington DC, USA. · Pitié-Salpêtrière Hospital, APHP, Paris 6 University, ICAN, Paris, France. · St George's Vascular Institute, St George's Healthcare NHS Trust, London, UK. · Department of Endocrinology, Skåne University Hospital, Malmö, Sweden. · Vice-Chancellors' Office, Cardiff University, Cardiff, UK. · Department of Diabetes and Endocrinology, Nottingham University Hospitals NHS Trust, Nottingham, UK. · ·Diabetes Metab Res Rev · Pubmed #26340818.

ABSTRACT: -- No abstract --

23 Guideline Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents. 2016

Schaper, N C / Van Netten, J J / Apelqvist, J / Lipsky, B A / Bakker, K / Anonymous730943. ·Div. Endocrinology, MUMC+, CARIM and CAPHRI Institutes, Maastricht, The Netherlands. · Department of Surgery, Ziekenhuisgroep Twente, Almelo and Hengelo, The Netherlands. · Department of Endocrinology, University Hospital of Malmö, Malmö, Sweden. · Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland, and University of Oxford, Oxford, UK. · IWGDF, Heemstede, The Netherlands. · ·Diabetes Metab Res Rev · Pubmed #26335366.

ABSTRACT: In this 'Summary Guidance for Daily Practice', we describe the basic principles of prevention and management of foot problems in persons with diabetes. This summary is based on the International Working Group on the Diabetic Foot (IWGDF) Guidance 2015. There are five key elements that underpin prevention of foot problems: (1) identification of the at-risk foot; (2) regular inspection and examination of the at-risk foot; (3) education of patient, family and healthcare providers; (4) routine wearing of appropriate footwear; and (5) treatment of pre-ulcerative signs. Healthcare providers should follow a standardized and consistent strategy for evaluating a foot wound, as this will guide further evaluation and therapy. The following items must be addressed: type, cause, site and depth, and signs of infection. There are seven key elements that underpin ulcer treatment: (1) relief of pressure and protection of the ulcer; (2) restoration of skin perfusion; (3) treatment of infection; (4) metabolic control and treatment of co-morbidity; (5) local wound care; (6) education for patient and relatives; and (7) prevention of recurrence. Finally, successful efforts to prevent and manage foot problems in diabetes depend upon a well-organized team, using a holistic approach in which the ulcer is seen as a sign of multi-organ disease, and integrating the various disciplines involved.

24 Guideline IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. 2016

Bus, S A / van Netten, J J / Lavery, L A / Monteiro-Soares, M / Rasmussen, A / Jubiz, Y / Price, P E / Anonymous700943. ·Department of Rehabilitation Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. · Diabetic Foot Clinic, Department of Surgery, Ziekenhuisgroep Twente, Almelo and Hengelo, the Netherlands. · Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA. · CIDES/CINTESIS - Health Information and Decision Sciences Department (U753-FCT), Faculty of Medicine of the University of Porto, Oporto, Portugal. · Steno Diabetes Center A/S, Gentofte, Denmark. · Diabetic Foot Unit, Colombian Diabetes Association, Bogotá, Colombia. · Vice Chancellors' Office, Cardiff University, Cardiff, Wales, UK. · ·Diabetes Metab Res Rev · Pubmed #26334001.

ABSTRACT: -- No abstract --

25 Guideline IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. 2016

Hinchliffe, R J / Brownrigg, J R W / Apelqvist, J / Boyko, E J / Fitridge, R / Mills, J L / Reekers, J / Shearman, C P / Zierler, R E / Schaper, N C / Anonymous670943. ·St George's Vascular Institute, St George's Healthcare NHS Trust, London, UK. · Department of Endocrinology, University Hospital of Malmö, Stockholm, Sweden. · Seattle Epidemiologic Research and Information Centre-Department of Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, WA, USA. · Vascular Surgery, The University of Adelaide, Adelaide, South Australia, Australia. · SALSA (Southern Arizona Limb Salvage Alliance), University of Arizona Health Sciences Center, Tucson, AZ, USA. · Department of Vascular Radiology, Amsterdam Medical Centre, Amsterdam, The Netherlands. · Department of Vascular Surgery, University Hospital Southampton NHS Foundation Trust, London, UK. · Department of Surgery, University of Washington, Seattle, WA, USA. · Division of Endocrinology, MUMC+, CARIM and CAPHRI Institute, Maastricht, The Netherlands. · ·Diabetes Metab Res Rev · Pubmed #26332424.

ABSTRACT: -- No abstract --

Next